Eyebright Medical Technology (Beijing) Co., Ltd.

XSSC:688050 Stock Report

Market Cap: CN¥14.1b

Eyebright Medical Technology (Beijing) Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Jiangbing Xie

Chief executive officer

CN¥1.5m

Total compensation

CEO salary percentagen/a
CEO tenure5yrs
CEO ownership12.9%
Management average tenureno data
Board average tenure5yrs

Recent management updates

Recent updates


CEO

Jiangbing Xie (52 yo)

5yrs

Tenure

CN¥1,482,600

Compensation

Mr. Jiangbing Xie serves as Chairman of the Board and General Manager at Eyebright Medical Technology (Beijing) Co., Ltd. since June 2019 and is its Chief Scientist.


Board Members

NamePositionTenureCompensationOwnership
Jiangbing Xie
Chairman of the Board5yrsCN¥1.48m12.92%
CN¥ 1.8b
Fang Yu
Director5yrsno datano data
Haiyan Wang
Independent Director5yrsCN¥108.30kno data
Feng Jiang
Independent Director2.4yrsno datano data
Yu Jiao Wang
Employee Supervisor5yrsno datano data
Yong Chen
Director2yrsno datano data
Lin Liang
Supervisor2yrsno datano data

5.0yrs

Average Tenure

52yo

Average Age

Experienced Board: 688050's board of directors are considered experienced (5 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.